Michael is a senior drug development professional with more than 20 years’ experience in the life sciences industry. He has served in senior leadership positions across disciplines including clinical and preclinical drug development, project and portfolio management, regulatory affairs and metabolism research. Most recent assignments were with Novartis Oncology, as Senior Global Program Manager and Polyphor Ltd., where he served as Head of Clinical and Preclinical Development. Under his leadership, several new oncology drugs were brought into clinical development, reaching clinical proof of concept and advancing further in development towards market authorization. Michael holds a PhD in Biotechnology and an MSc in Chemistry.

Oscar is an EPFL PhD and serial entrepreneur with a track record of spinning out hightechnology/deep-science innovations from leading European universities. Oscar’s 1st startup saw him spin out his own PhD thesis to create Snaketech, an electronic design automation software company, which grew from 2 to 30 people in 4 years before merging with Simplex Solutions in 2000 and making an initial public offering on the Nasdaq in 2001. His most recent startup, Anokion, is a biotechnology company focused on immune tolerance that grew from 4 to over 50 people and is now starting clinical trials.

Mr. Jiang is Founding Partner and CEO of Shanghai Yafo Capital, investment & advisory boutique focused on the Life Sciences. He has over 20 years Wall Street experience in investment banking and direct investments in global biopharma companies. Sean held a position as Chinese General Manager of ISI Group (NY) and Managing Director of ISI Research. He was also Senior Research Analyst at Roth Capital (LA) where he was involved in several cross-border transactions. When at Xiangcai Securities, Sean was the Executive Director, responsible for advising foreign institutional investors in China’s capital markets. He is CFA holder.

Fiona focuses on cross-border transactions (foreign direct investment, M&A, corporate and commercial) and Life Sciences. She advises Swiss and international clients, in particular Chinese clients, of all sizes.

With over 10 years of multi-jurisdictional (China, Switzerland, U.S.) legal advisory experiences in leading law firms and in in-house team of multinational companies, she brings a unique and comprehensive legal expertise to Sino-Swiss clients.